{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:09:21Z","timestamp":1794276561520,"version":"4.9.0"},"reference-count":86,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Gastrointestinal (GI) cancers are the second leading cause of cancer-related deaths worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>The global challenges GI cancers pose are high, especially in middle- and low-income countries. Patients with these cancers present with symptoms of poor appetite, weight loss, heartburn, abdominal pain, fatigue and anaemia. Several risk factors contribute to GI cancers, including age, gender, obesity, pathogenic infections, smoking cigarettes, alcohol consumption and dietary habits. Most of these cancers are sporadic. However, some patients are at high risk due to a family history of GI cancers. Systemic diseases affect multiple organs, and their chronic occurrence elicits inflammatory responses at various sites. These diseases also contribute to GI cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Relevance<\/jats:title>\n                    <jats:p>In this review, we discuss that untreated systemic diseases, including diabetes, hepatitis, acquired immune deficiency syndrome, ulcers and hypertension, can potentially lead to GI cancers if they remain untreated for a longer period. Systemic diseases initiate oxidative stress, inflammatory pathways and genetic manipulations, which altogether confer risks to GI cancers. Here, we describe the association between systemic diseases and their underlying mechanisms leading to GI cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.37029\/jcas.v9i2.473","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T19:43:43Z","timestamp":1691696623000},"page":"1-12","source":"Crossref","is-referenced-by-count":15,"title":["Systemic Diseases and Gastrointestinal Cancer Risk"],"prefix":"10.2478","volume":"9","author":[{"given":"Naila","family":"Malkani","sequence":"first","affiliation":[{"name":"Department of Zoology , Government College University , Lahore, Punjab , Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usman","family":"Rashid","sequence":"additional","affiliation":[{"name":"Department of Basic Sciences Research , Shaukat Khanum Memorial Cancer Hospital and Research Centre , Lahore, Punjab , Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"2026091912310703150_j_jcas.v9i2.473_ref_001","doi-asserted-by":"crossref","unstructured":"Leung PS, editor. The Gastrointestinal System: Gastrointestinal, Nutritional and Hepatobiliary Physiology. Berlin: Springer Science and Business; 2014.","DOI":"10.1007\/978-94-017-8771-0"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_002","doi-asserted-by":"crossref","unstructured":"Boland CR, Luciani MG, Gasche C, Goel A. Infection, inflammation, and gastrointestinal cancer. Gut 2005;54:1321-31.","DOI":"10.1136\/gut.2004.060079"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_003","doi-asserted-by":"crossref","unstructured":"Cherwin CH. Gastrointestinal symptom representation in cancer symptom clusters: A synthesis of the literature. Oncol Nurs Forum 2012;39:157-65.","DOI":"10.1188\/12.ONF.157-165"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_004","doi-asserted-by":"crossref","unstructured":"Katabathina VS, Menias CO, Khanna L, Murphy L, Dasyam AK, Lubner MG, et al. Hereditary gastrointestinal cancer syndromes: Role of imaging in screening, diagnosis, and management. Radiographics 2019;39:1280-301.","DOI":"10.1148\/rg.2019180185"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_005","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.","DOI":"10.3322\/caac.21660"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_006","doi-asserted-by":"crossref","unstructured":"Mealy K, Feely J, Reid I, McSweeney J, Walsh T, Hennessy TP. Tumour marker detection in oesophageal carcinoma. Eur J Surg Oncol 1996;22:505-7.","DOI":"10.1016\/S0748-7983(96)92998-4"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_007","doi-asserted-by":"crossref","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 2020;159:335-49.e15.","DOI":"10.1053\/j.gastro.2020.02.068"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_008","doi-asserted-by":"crossref","unstructured":"Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett 2016;11:2959-64.","DOI":"10.3892\/ol.2016.4337"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_009","doi-asserted-by":"crossref","unstructured":"C\u0103inap C, Nagy V, Gherman A, Cetean S, Laszlo I, Constantin AM, et al. Classic tumor markers in gastric cancer. Current standards and limitations. Clujul Med 2015;88:111-5.","DOI":"10.15386\/cjmed-409"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_010","doi-asserted-by":"crossref","unstructured":"Yuen MF, Lai CL. Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 2005;19:91-9.","DOI":"10.1016\/j.bpg.2004.10.003"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_011","doi-asserted-by":"crossref","unstructured":"R\u00fcckert F, Pilarsky C, Gr\u00fctzmann R. Serum tumor markers in pancreatic cancer-recent discoveries. Cancers (Basel) 2010;2:1107-24.","DOI":"10.3390\/cancers2021107"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_012","doi-asserted-by":"crossref","unstructured":"Jelski W, Mroczko B. Biochemical markers of colorectal cancer - present and future. Cancer Manag Res 2020;12:4789-97.","DOI":"10.2147\/CMAR.S253369"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_013","doi-asserted-by":"crossref","unstructured":"Karczewski J, Begier-Krasi\u0144ska B, Staszewski R, Pop\u0142awska E, Gulczynska-Elhadi K, Dobrowolska A. Obesity and the risk of gastrointestinal cancers. Dig Dis Sci 2019;64:2740-9.","DOI":"10.1007\/s10620-019-05603-9"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_014","doi-asserted-by":"crossref","unstructured":"Donohoe CL, O\u2019Farrell NJ, Doyle SL, Reynolds JV. The role of obesity in gastrointestinal cancer: Evidence and opinion. Therap Adv Gastroenterol 2014;7:38-50.","DOI":"10.1177\/1756283X13501786"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_015","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan J, Lysaght J, Donohoe CL, Reynolds JV. Obesity and gastrointestinal cancer: The interrelationship of adipose and tumour microenvironments. Nat Rev Gastroenterol Hepatol 2018;15:699-714.","DOI":"10.1038\/s41575-018-0069-7"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_016","doi-asserted-by":"crossref","unstructured":"Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev 2005;14:459-66.","DOI":"10.1158\/1055-9965.EPI-04-0583"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_017","doi-asserted-by":"crossref","unstructured":"Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M. Worldwide burden of cancer attributable to diabetes and high body-mass index: A comparative risk assessment. Lancet Diabetes Endocrinol 2018;6:95-104.","DOI":"10.1016\/S2213-8587(17)30366-2"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_018","doi-asserted-by":"crossref","unstructured":"Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol 2013;24:609-17.","DOI":"10.1093\/annonc\/mds244"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_019","doi-asserted-by":"crossref","unstructured":"Cameron AJ, Romero Y. Symptomatic gastrooesophageal reflux as a risk factor for oesophageal adenocarcinoma. Gut 2000;46:754-5.","DOI":"10.1136\/gut.46.6.754"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_020","doi-asserted-by":"crossref","unstructured":"Kern L, Mittenb\u00fchler MJ, Vesting AJ, Ostermann AL, Wunderlich CM, Wunderlich FT. Obesity-induced TNF\u03b1 and IL-6 signaling: The missing link between obesity and inflammation-driven liver and colorectal cancers. Cancers (Basel) 2018;11:24.","DOI":"10.3390\/cancers11010024"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_021","doi-asserted-by":"crossref","unstructured":"Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res 2016;118:1786-807.","DOI":"10.1161\/CIRCRESAHA.115.306885"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_022","doi-asserted-by":"crossref","unstructured":"Francisco V, Pino J, Campos-Cabaleiro V, Ruiz-Fern\u00e1ndez C, Mera A, Gonzalez-Gay MA, et al. Obesity, fat mass and immune system: Role for leptin. Front Physiol 2018;9:640.","DOI":"10.3389\/fphys.2018.00640"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_023","doi-asserted-by":"crossref","unstructured":"Corvera S, Gealekman O. Adipose tissue angiogenesis: Impact on obesity and Type-2 diabetes. Biochim Biophys Acta 2014;1842:463-72.","DOI":"10.1016\/j.bbadis.2013.06.003"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_024","doi-asserted-by":"crossref","unstructured":"Anderson MA, Zolotarevsky E, Cooper KL, Sherman S, Shats O, Whitcomb DC, et al. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: A multicenter study. Am J Gastroenterol 2012;107:1730-9.","DOI":"10.1038\/ajg.2012.288"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_025","doi-asserted-by":"crossref","unstructured":"Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: An overall and dose-response meta-analysis of published studies. Ann Oncol 2011;22:1958-72.","DOI":"10.1093\/annonc\/mdq653"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_026","doi-asserted-by":"crossref","unstructured":"Scher\u00fcbl H. Alcohol use and gastrointestinal cancer risk. Visc Med 2020;36:175-81.","DOI":"10.1159\/000507232"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_027","doi-asserted-by":"crossref","unstructured":"McMenamin \u00daC, McCain S, Kunzmann AT. Do smoking and alcohol behaviours influence GI cancer survival? Best Pract Res Clin Gastroenterol 2017;31:569-77.","DOI":"10.1016\/j.bpg.2017.09.015"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_028","doi-asserted-by":"crossref","unstructured":"Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V. Alcohol consumption, smoking and risk of gastric cancer: Case-control study from Moscow, Russia. Cancer Causes Control 2000;11:363-71.","DOI":"10.1023\/A:1008907924938"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_029","doi-asserted-by":"crossref","unstructured":"di Pietro M, Alzoubaidi D, Fitzgerald RC. Barrett\u2019s esophagus and cancer risk: How research advances can impact clinical practice. Gut Liver 2014;8:356-70.","DOI":"10.5009\/gnl.2014.8.4.356"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_030","doi-asserted-by":"crossref","unstructured":"Bucchi D, Stracci F, Buonora N, Masanotti G. Human papillomavirus and gastrointestinal cancer: A review. World J Gastroenterol 2016;22:7415-30.","DOI":"10.3748\/wjg.v22.i33.7415"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_031","doi-asserted-by":"crossref","unstructured":"Ignatova E, Seriak D, Fedyanin M, Tryakin A, Pokataev I, Menshikova S, et al. Epstein-Barr virus-associated gastric cancer: Disease that requires special approach. Gastric Cancer 2020;23:951-60.","DOI":"10.1007\/s10120-020-01095-z"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_032","doi-asserted-by":"crossref","unstructured":"Tavakolian S, Goudarzi H, Kazeminezhad B, Faghihloo E. Prevalence of herpes simplex, varicella zoster and Cytomegalovirus in tumorous and adjacent tissues of patients, suffering from colorectal cancer in Iran. Transl Med Commun 2019;4:20.","DOI":"10.1186\/s41231-019-0051-6"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_033","doi-asserted-by":"crossref","unstructured":"Lv YL, Han FF, An ZL, Jia Y, Xuan LL, Gong LL, et al. Cytomegalovirus infection is a risk factor in gastrointestinal cancer: A cross-sectional and meta-analysis study. Intervirology 2020;63:10-6.","DOI":"10.1159\/000506683"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_034","doi-asserted-by":"crossref","unstructured":"Wroblewski LE, Peek RM Jr., Wilson KT. Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clin Microbiol Rev 2010;23:713-39.","DOI":"10.1128\/CMR.00011-10"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_035","doi-asserted-by":"crossref","unstructured":"Moazzen S, van der Sloot KW, Vonk RJ, de Bock GH, Alizadeh BZ. Diet quality and upper gastrointestinal cancers risk: A meta-analysis and critical assessment of evidence quality. Nutrients 2020;12:1863.","DOI":"10.3390\/nu12061863"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_036","doi-asserted-by":"crossref","unstructured":"Maga T, Balay L, Jung B. Advantages and some remaining challenges in hereditary gastrointestinal cancer panel testing. Clin Transl Gastroenterol 2017;8:e92.","DOI":"10.1038\/ctg.2017.19"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_037","doi-asserted-by":"crossref","unstructured":"Rashid MU, Naeemi H, Muhammad N, Loya A, Lubi\u0144ski J, Jakubowska A, et al. Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients. Hered Cancer Clin Pract 2019;17:29.","DOI":"10.1186\/s13053-019-0128-2"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_038","doi-asserted-by":"crossref","unstructured":"Muhammad N, Sadaqat R, Naeemi H, Masood I, Hassan U, Ijaz B, et al. Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan. HPB (Oxford) 2022;24:2134-44.","DOI":"10.1016\/j.hpb.2022.09.003"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_039","unstructured":"Jencks DS, Adam JD, Borum ML, Koh JM, Stephen S, Doman DB. Overview of current concepts in gastric intestinal metaplasia and gastric cancer. Gastroenterol Hepatol (N Y) 2018;14:92-101."},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_040","doi-asserted-by":"crossref","unstructured":"Fakhruddin S, Alanazi W, Jackson KE. Diabetes-induced reactive oxygen species: Mechanism of their generation and role in renal injury. J Diabetes Res 2017;2017:8379327.","DOI":"10.1155\/2017\/8379327"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_041","doi-asserted-by":"crossref","unstructured":"Srinivas US, Tan BW, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol 2019;25:101084.","DOI":"10.1016\/j.redox.2018.101084"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_042","doi-asserted-by":"crossref","unstructured":"Samuel SM, Varghese E, Varghese S, B\u00fcsselberg D. Challenges and perspectives in the treatment of diabetes associated breast cancer. Cancer Treat Rev 2018;70:98-111.","DOI":"10.1016\/j.ctrv.2018.08.004"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_043","doi-asserted-by":"crossref","unstructured":"Dixon JL, Copeland LA, Zeber JE, MacCarthy AA, Reznik SI, Smythe WR, et al. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population. Dis Esophagus 2016;29:747-51.","DOI":"10.1111\/dote.12402"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_044","doi-asserted-by":"crossref","unstructured":"Xu B, Zhou X, Li X, Liu C, Yang C. Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis. Medicine (Baltimore) 2017;96:e7944.","DOI":"10.1097\/MD.0000000000007944"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_045","doi-asserted-by":"crossref","unstructured":"Mantovani A, Targher G. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: Spotlight on nonalcoholic fatty liver disease. Ann Transl Med 2017;5:270.","DOI":"10.21037\/atm.2017.04.41"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_046","doi-asserted-by":"crossref","unstructured":"El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.","DOI":"10.1053\/j.gastro.2003.10.065"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_047","doi-asserted-by":"crossref","unstructured":"Petrick JL, Freedman ND, Demuth J, Yang B, Van Den Eeden SK, Engel LS, et al. Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race\/ethnicity, and sex: Multiphasic health checkup study. Cancer Epidemiol 2016;42:140-6.","DOI":"10.1016\/j.canep.2016.04.009"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_048","doi-asserted-by":"crossref","unstructured":"Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study. Gut 2005;54:533-9.","DOI":"10.1136\/gut.2004.052167"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_049","doi-asserted-by":"crossref","unstructured":"Bjornsdottir HH, Rawshani A, Rawshani A, Franz\u00e9n S, Svensson AM, Sattar N, et al. A national observation study of cancer incidence and mortality risks in Type 2 diabetes compared to the background population over time. Sci Rep 2020;10:17376.","DOI":"10.1038\/s41598-020-73668-y"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_050","doi-asserted-by":"crossref","unstructured":"Yoon JM, Son KY, Eom CS, Durrance D, Park SM. Preexisting diabetes mellitus increases the risk of gastric cancer: A meta-analysis. World J Gastroenterol 2013;19:936-45.","DOI":"10.3748\/wjg.v19.i6.936"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_051","doi-asserted-by":"crossref","unstructured":"Cheung KS, Chan EW, Chen L, Seto WK, Wong IC, Leung WK. Diabetes increases risk of gastric cancer after Helicobacter pylori eradication: A territory-wide study with propensity score analysis. Diabetes Care 2019;42:1769-75.","DOI":"10.2337\/dc19-0437"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_052","unstructured":"Yang HJ, Kang D, Chang Y, Ahn J, Ryu S, Cho J, et al. Diabetes mellitus is associated with an increased risk of gastric cancer: A cohort study. Gastric Cancer 2019;18:1-9."},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_053","doi-asserted-by":"crossref","unstructured":"Marimuthu SP, Vijayaragavan P, Moysich KB, Jayaprakash V. Diabetes mellitus and gastric carcinoma: Is there an association? J Carcinog 2011;10:30.","DOI":"10.4103\/1477-3163.90481"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_054","doi-asserted-by":"crossref","unstructured":"Dulskas A, Patasius A, Kaceniene A, Linkeviciute-Ulinskiene D, Zabuliene L, Smailyte G. A cohort study of antihyperglycemic medication exposure and gastric cancer risk. J Clin Med 2020;9:435.","DOI":"10.3390\/jcm9020435"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_055","doi-asserted-by":"crossref","unstructured":"Li D. Diabetes and pancreatic cancer. Mol Carcinog 2012;51:64-74.","DOI":"10.1002\/mc.20771"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_056","doi-asserted-by":"crossref","unstructured":"Zhang Q, Zeng L, Chen Y, Lian G, Qian C, Chen S, et al. Pancreatic cancer epidemiology, detection, and management. Gastroenterol Res Pract 2016;2016:8962321.","DOI":"10.1155\/2016\/8962321"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_057","doi-asserted-by":"crossref","unstructured":"Ma Y, Yang W, Song M, Smith-Warner SA, Yang J, Li Y, et al. Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts. Br J Cancer 2018;119:1436-42.","DOI":"10.1038\/s41416-018-0314-4"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_058","doi-asserted-by":"crossref","unstructured":"Peeters PJ, Bazelier MT, Leufkens HG, de Vries F, De Bruin ML. The risk of colorectal cancer in patients with Type 2 diabetes: Associations with treatment stage and obesity. Diabetes Care 2015;38:495-502.","DOI":"10.2337\/dc14-1175"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_059","doi-asserted-by":"crossref","unstructured":"Fang HJ, Shan SB, Zhou YH, Zhong LY. Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: A meta-analysis of cohort studies. BMC Cancer 2018;18:422.","DOI":"10.1186\/s12885-018-4351-4"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_060","doi-asserted-by":"crossref","unstructured":"de Oliveria Andrade LJ, D\u2019Oliveira A, Junior RC, De Souza EC, Silva CA, Parana R. Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis 2009;1:33-7.","DOI":"10.4103\/0974-777X.52979"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_061","doi-asserted-by":"crossref","unstructured":"Tarocchi M, Polvani S, Marroncini G, Galli A. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 2014;20:11630-40.","DOI":"10.3748\/wjg.v20.i33.11630"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_062","doi-asserted-by":"crossref","unstructured":"Vescovo T, Refolo G, Vitagliano G, Fimia GM, Piacentini MJ. Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma. Clin Microbiol Infect 2016;22:853-61.","DOI":"10.1016\/j.cmi.2016.07.019"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_063","doi-asserted-by":"crossref","unstructured":"Li H, Huang MH, Jiang JD, Peng ZG. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory\/ hepatoprotective therapy. World J Gastroenterol 2018;24:5297-311.","DOI":"10.3748\/wjg.v24.i47.5297"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_064","doi-asserted-by":"crossref","unstructured":"Song C, Lv J, Liu Y, Chen JG, Ge Z, Zhu J, et al. Associations between hepatitis B Virus infection and risk of all cancer types. JAMA Netw Open 2019;2:e195718.","DOI":"10.1001\/jamanetworkopen.2019.5718"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_065","doi-asserted-by":"crossref","unstructured":"Kamiza AB, Su FH, Wang WC, Sung FC, Chang SN, Yeh CC. Chronic hepatitis infection is associated with extrahepatic cancer development: A nationwide population-based study in Taiwan. BMC Cancer 2016;16:861.","DOI":"10.1186\/s12885-016-2918-5"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_066","doi-asserted-by":"crossref","unstructured":"Qadwai S, Rehman T, Barsa J, Solangi Z, Lebovics E. Hepatitis C virus and nonliver solid cancers: Is there an association between HCV and cancers of the pancreas, thyroid, kidney, oral cavity, breast, lung, and gastrointestinal tract? Gastroenterol Res Pract 2017;2017:8349150.","DOI":"10.1155\/2017\/8349150"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_067","doi-asserted-by":"crossref","unstructured":"Zilberman-Schapira G, Zmora N, Itav S, Bashiardes S, Elinav H, Elinav E. The gut microbiome in human immunodeficiency virus infection. BMC Med 2016;14:83.","DOI":"10.1186\/s12916-016-0625-3"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_068","doi-asserted-by":"crossref","unstructured":"Okoye AA, Picker LJ. CD 4+ T\u2010cell depletion in HIV infection: Mechanisms of immunological failure. Immunol Rev 2013;254:54-64.","DOI":"10.1111\/imr.12066"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_069","doi-asserted-by":"crossref","unstructured":"Persson EC, Shiels MS, Dawsey SM, Bhatia K, Anderson LA, Engels EA. Retracted: Increased risk of stomach and esophageal malignancies in people with AIDS. Gastroenterology 2012;143:943-50.e2.","DOI":"10.1053\/j.gastro.2012.07.013"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_070","doi-asserted-by":"crossref","unstructured":"Hu J, Liu K, Luo J. HIV-HBV and HIV-HCV coinfection and liver cancer development. In: HIV\/AIDS-Associated Viral Oncogenesis. Cham: Springer; 2019. p. 231-50.","DOI":"10.1007\/978-3-030-03502-0_9"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_071","doi-asserted-by":"crossref","unstructured":"Otedo A, Simbiri KO, Were V, Ongati O, Estambale BA. Risk factors for liver Cancer in HIV endemic areas of Western Kenya. Infect Agent Cancer 2018;13:41.","DOI":"10.1186\/s13027-018-0214-5"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_072","doi-asserted-by":"crossref","unstructured":"Br\u00e4u N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, et al. North American Liver Cancer in HIV Study Group: Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A US-Canadian multicenter study. J Hepatol 2007;47:527-37.","DOI":"10.1016\/j.jhep.2007.06.010"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_073","doi-asserted-by":"crossref","unstructured":"O\u02bcNeill TJ, Nguemo JD, Tynan AM, Burchell AN, Antoniou T. Risk of colorectal cancer and associated mortality in HIV: A systematic review and meta-analysis. J Acquir Immune Defic Syndr 2017;75:439-47.","DOI":"10.1097\/QAI.0000000000001433"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_074","doi-asserted-by":"crossref","unstructured":"Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008;134:306-23.","DOI":"10.1053\/j.gastro.2007.11.009"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_075","doi-asserted-by":"crossref","unstructured":"Cheung KS, Leung WK. Long-term use of proton-pump inhibitors and risk of gastric cancer: A review of the current evidence. Therap Adv Gastroenterol 2019;12:1756284819834511.","DOI":"10.1177\/1756284819834511"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_076","doi-asserted-by":"crossref","unstructured":"Abrahami D, McDonald EG, Schnitzer ME, Barkun AN, Suissa S, Azoulay L. Proton pump inhibitors and risk of gastric cancer: Population-based cohort study. Gut 2022;71:16-24.","DOI":"10.1136\/gutjnl-2021-325097"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_077","doi-asserted-by":"crossref","unstructured":"S\u00f8gaard KK, Farkas DK, Pedersen L, Lund JL, Thomsen RW, S\u00f8rensen HT. Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers. Cancer Med 2016;5:1341-51.","DOI":"10.1002\/cam4.680"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_078","doi-asserted-by":"crossref","unstructured":"Hansson LE, Nyr\u00e9n O, Hsing AW, Bergstr\u00f6m R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9.","DOI":"10.1056\/NEJM199607253350404"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_079","doi-asserted-by":"crossref","unstructured":"Molloy RM, Sonnenberg A. Relation between gastric cancer and previous peptic ulcer disease. Gut 1997;40:247-52.","DOI":"10.1136\/gut.40.2.247"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_080","doi-asserted-by":"crossref","unstructured":"Grossman E, Messerli FH, Boyko V, Goldbourt U. Is there an association between hypertension and cancer mortality? Am J Med 2002;112:479-86.","DOI":"10.1016\/S0002-9343(02)01049-5"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_081","doi-asserted-by":"crossref","unstructured":"Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, et al. Inflammation, immunity, and hypertension. Hypertension 2011;57:132-40.","DOI":"10.1161\/HYPERTENSIONAHA.110.163576"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_082","doi-asserted-by":"crossref","unstructured":"Wang Z, White DL, Hoogeveen R, Chen L, Whitsel EA, Richardson PA, et al. Anti-hypertensive medication use, soluble receptor for glycation end products and risk of pancreatic cancer in the women\u2019s health initiative study. J Clin Med 2018;7:197.","DOI":"10.3390\/jcm7080197"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_083","doi-asserted-by":"crossref","unstructured":"Makar GA, Holmes JH, Yang YX. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst 2014;106:djt374.","DOI":"10.1093\/jnci\/djt374"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_084","doi-asserted-by":"crossref","unstructured":"Seretis A, Cividini S, Markozannes G, Tseretopoulou X, Lopez DS, Ntzani EE, et al. Association between blood pressure and risk of cancer development: A systematic review and meta-analysis of observational studies. Sci Rep 2019;9:8565.","DOI":"10.1038\/s41598-019-45014-4"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_085","doi-asserted-by":"crossref","unstructured":"Koz\u0142owska K, Koz\u0142owski L, Ma\u0142yszko J. Hypertension prevalence in early breast cancer patients undergoing primary surgery. Adv Med Sci 2019;64:32-6.","DOI":"10.1016\/j.advms.2018.10.003"},{"key":"2026091912310703150_j_jcas.v9i2.473_ref_086","doi-asserted-by":"crossref","unstructured":"Christakoudi S, Kakourou A, Markozannes G, Tzoulaki I, Weiderpass E, Brennan P, et al. Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2020;146:2680-93.","DOI":"10.1002\/ijc.32576"}],"container-title":["Journal of Cancer and Allied Specialties"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sfu.ca\/jcas\/index.php\/jcas\/article\/download\/473\/483","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.37029\/jcas.v9i2.473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:46:09Z","timestamp":1789821969000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.37029\/jcas.v9i2.473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":86,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8,9]]},"published-print":{"date-parts":[[2023,8,1]]}},"alternative-id":["10.37029\/jcas.v9i2.473"],"URL":"https:\/\/doi.org\/10.37029\/jcas.v9i2.473","relation":{},"ISSN":["2411-989X"],"issn-type":[{"value":"2411-989X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}